The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells
Open accessAbstract
Introduction: A physiological feature of many tumor tissues and cells is the tendency to accumulate high concentrations of copper. While the precise role of copper in tumors is cryptic, copper, but not other trace metals, is required for angiogenesis. We have recently reported that organic copper-containing compounds, including 8-hydroxyquinoline-copper(II) and 5,7-dichloro-8-hydroxyquinoline-copper(II), comprise a novel class of proteasome inhibitors and tumor cell apoptosis inducers. In the current study, we investigate whether clioquinol (CQ), an analog of 8-hydroxyquinoline and an Alzheimer's disease drug, and pyrrolidine dithiocarbamate (PDTC), a known copper-binding compound and antioxidant, can interact with copper to form cancer-specific proteasome inhibitors and apoptosis inducers in human breast cancer cells. Tetrathiomolybdate (TM), a strong copper chelator currently being tested in clinical trials, is used as a comparison. Methods: Breast cell lines, normal, immortalized MCF-10A, premalignant MCF10AT1K.cl2, and malignant MCF10DCIS.com and MDA-MB-231, were treated with CQ or PDTC with or without prior interaction with copper, followed by measurement of proteasome inhibition and cell death. Inhibition of the proteasome was determined by levels of the proteasomal chymotrypsin-like activity and ubiquitinated proteins in protein extracts of the treated cells. Apoptotic cell death was measured by morphological changes, Hoechst staining, and poly(ADP-ribose) polymerase cleavage. Results: When in complex with copper, both CQ and PDTC, but not TM, can inhibit the proteasome chymotrypsin-like activity, block proliferation, and induce apoptotic cell death preferentially in breast cancer cells, less in premalignant breast cells, but are non-toxic to normal/non-transformed breast cells at the concentrations tested. In contrast, CQ, PDTC, TM or copper alone had no effects on any of the cells. Breast premalignant or cancer cells that contain copper at concentrations similar to those found in patients, when treated with just CQ or PDTC alone, but not TM, undergo proteasome inhibition and apoptosis. Conclusion: The feature of breast cancer cells and tissues to accumulate copper can be used as a targeting method for anticancer therapy through treatment with novel compounds such as CQ and PDTC that become active proteasome inhibitors and breast cancer cell killers in the presence of copper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Goycoolea, A. (1997) · Cited by 3,615
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., & Earnshaw, W. C. (1994) · Nature · doi:10.1038/371346a0 · Cited by 2,562
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,479
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 3×
“Recently, interest in CQ has reemerged due to studies involving its use, in combination with B12, for treatment of Alzheimer's disease [ 43 ,49,50].”
InfluentialRitchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Ubiquitin, proteasomes, and the regulation of intracellular protein degradation
Hochstrasser, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80031-x · Cited by 874
Proteasome from Thermoplasma acidophilum : a Threonine Protease
Seemüller, E., Lupas, A., Stock, D., Löwe, J., Huber, R., & Baumeister, W. (1995) · Science · doi:10.1126/science.7725107 · Cited by 634
The proteasome: a novel target for cancer chemotherapy
Almond, J., & Cohen, G. (2002) · Leukemia · doi:10.1038/sj.leu.2402417 · Cited by 538
Earnshaw, W. C. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80088-3 · Cited by 530
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Pan, Q., Kleer, C. G., van Golen, K. L., Irani, J., Bottema, K. M., Bias, C., Carvalho, M. D., Mesri, E. A., Robins, D. M., Dick, R. D., et al. (2002) · PubMed · Cited by 500
Activation of the cell death program by inhibition of proteasome function
Drexler, H. C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.855 · Cited by 481
p53-dependent Induction of Apoptosis by Proteasome Inhibitors
Lopes, U. G., Erhardt, P., Yao, R., & Cooper, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12893 · Cited by 467
Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells
Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H., & Miller, F. R. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006461422273 · Cited by 408
Self-citationDevelopment of the Proteasome Inhibitor PS-341
Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 369
Theophanides, T., & Anastassopoulou, J. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00007-0 · Cited by 349
Brewer, G. J., Dick, R. D., Grover, D. K., LeClaire, V., Tseng, M., Wicha, M. S., Pienta, K. J., Redman, B. G., Jahan, T. M., Sondak, V. K., et al. (2000) · PubMed · Cited by 347
An, B., Goldfarb, R. H., Siman, R., & Dou, Q. P. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400436 · Cited by 337
Self-citationDisulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells
Cen, D., Brayton, D., Shahandeh, B., Meyskens, & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 334
Copper and Zinc levels in normal and malignant tissues
Margalioth, E. J., Schenker, J. G., & Chevion, M. (1983) · Cancer · doi:10.1002/1097-0142(19830901)52:5<868::aid-cncr2820520521>3.0.co;2-k · Cited by 301
Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., & Zatta, P. (2004) · Inorganic Chemistry · doi:10.1021/ic0494051 · Cited by 292
Serum and Tissue Trace Elements in Patients with Breast Cancer in Taiwan
Kuo, H. W., Chen, S. F., Wu, C. C., Chen, D. R., & Lee, J. H. (2002) · Biological Trace Element Research · doi:10.1385/bter:89:1:1 · Cited by 267
Self-citationAssociation between oxidative stress and changes of trace elements in patients with breast cancer
Huang, Y.-L., Sheu, J.-Y., & Lin, T.-H. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00096-4 · Cited by 265
Anticancer Activity of the Antibiotic Clioquinol
Ding, W.-Q., Liu, B., Vaught, J. L., Yamauchi, H., & Lind, S. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3577 · Cited by 248
Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.
Jänicke, R. U., Walker, P. A., Lin, X. Y., & Porter, A. G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01089.x · Cited by 247
Apoptosis induction resulting from proteasome inhibition
SHINOHARA, K., TOMIOKA, M., NAKANO, H., TONÉ, S., ITO, H., & KAWASHIMA, S. (1996) · Biochemical Journal · doi:10.1042/bj3170385 · Cited by 244
Fox, S. B., Gasparini, G., & Harris, A. L. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00323-5 · Cited by 230
Treatment of Alzheimer’s Disease with Clioquinol
Regland, B., Lehmann, W., Abedini, I., Blennow, K., Jonsson, M., Karlsson, I., Sjögren, M., Wallin, A., Xilinas, M., & Gottfries, C.-G. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051288 · Cited by 220
Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study
Geraki, K., Farquharson, M. J., & Bradley, D. A. (2002) · Physics in Medicine and Biology · doi:10.1088/0031-9155/47/13/310 · Cited by 214
Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 Cells
Imajohohmi, S., Kawaguchi, T., Sugiyama, S., Tanaka, K., Omura, S., & Kikuchi, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2878 · Cited by 206
An, B., & Dou, Q. P. (1996) · PubMed · Cited by 205
Self-citationCopper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease
Brewer, G. J. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020222600712 · Cited by 179
Degradation of Retinoblastoma Protein in Tumor Necrosis Factor- and CD95-induced Cell Death
Tan, X., Martin, S. J., Green, D. R., & Wang, J. Y. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9613 · Cited by 170
Serum and Tissue Trace Metal Levels in Lung Cancer
Díez, M., Arroyo, M., Cerdàn, F. J., Muñoz, M., Martin, M. A., & Balibrea, J. L. (1989) · Oncology · doi:10.1159/000226722 · Cited by 161
Proteasome inhibitors as potential novel anticancer agents
Dou, Q. P., & Li, B. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0095 · Cited by 158
Self-citationFIBRE, DIABETES, AND HYPERLIPIDÆMIA
Mann, J. I., Simpson, H. C. R., & Yudkin, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90581-4 · Cited by 155
Copper storage diseases: Menkes, Wilson's, and Cancer
Kenyon, G. L. (2004) · Frontiers in bioscience · doi:10.2741/1424 · Cited by 146
Tumour vasculature as a target for anticancer therapy
Eatock, M. M., Schätzlein, A. G., & Kaye, S. B. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0158 · Cited by 139
Angiogenesis and Cancer Control: From Concept to Therapeutic Trial
Brem, S. S. (1999) · Cancer Control · doi:10.1177/107327489900600502 · Cited by 135
Copper and ceruloplasmin status in serum of prostate and colon cancer patients.
Nayak, S. B., Bhat, V. R., Upadhyay, D., & Udupa, S. L. (2003) · PubMed · Cited by 127
Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol
Yassin, M. S., Ekblom, J., Xilinas, M., Gottfries, C. G., & Oreland, L. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00297-x · Cited by 123
Pipes and wiring: the regulation of copper uptake and distribution in yeast
Labbé, S., & Thiele, D. J. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01638-8 · Cited by 120
Interleukin-1β Induction of Mitogen-activated Protein Kinases in Human Mesangial Cells
Wilmer, W. A., Tan, L. C., Dickerson, J. A., Danne, M. M., & Rovin, B. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10877 · Cited by 114
Subacute myelo‐optico‐neuropathy: Clioquinol intoxication in humans and animals
Tateishi, J. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00296.x · Cited by 92
Radiotherapy and Antiangiogenic TM in Lung Cancer
Khan, M. K., Miller, M. W., Taylor, J. M. G., Gill, N. K., Dick, R. D., Goled, K. V., Brewert, G. J., & Merajver, S. D. (2002) · Neoplasia · doi:10.1038/sj.neo.7900218 · Cited by 85
Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Gourley, M. J., & Williamson, J. S. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003400867 · Cited by 85
Parodi, F. E., Mao, D., Ennis, T. L., Bartoli, M. A., & Thompson, R. W. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.12.030 · Cited by 65
Chan, A. Y. F., Wong, F., & Arumanayagam, M. (1993) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329303000603 · Cited by 64
Ding, W., Tang, Q., Espina, V. A., Liotta, L. A., Mauger, D. T., & Mulder, K. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4385 · Cited by 59
Furuta, S., ORTIZ, F., Sun, X. Z., Wu, H., Mason, A. Z., & Momand, J. A. (2002) · Biochemical Journal · doi:10.1042/bj20011251 · Cited by 42
Cell death in human acute myelogenous leukemic cells induced by pyrrolidinedithiocarbamate
Malaguarnera, L., Pilastro, M. R., Marco, R. D., Scifo, C., Renis, M., Mazzarino, M. C., & Messina, A. (2003) · APOPTOSIS · doi:10.1023/a:1025550726803 · Cited by 37
Prophylactic value of clioquinol against travellers' diarrhœa
Richards, D. A. (1971) · The Lancet · doi:10.1016/s0140-6736(71)80056-9 · Cited by 37
Aggett, P. J., & Fairweather‐Tait, S. J. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.1061 · Cited by 36
Angiogenesis Inhibitors: New Agents in Cancer Therapy
Ryan, C. J., & Wilding, G. (2000) · Drugs & Aging · doi:10.2165/00002512-200017040-00001 · Cited by 34
Pharmacological proteasome inhibitors and their therapeutic potential
Dou, Q. P., & Nam, S. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.8.1263 · Cited by 23
Self-citationCole, G. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00160-0 · Cited by 21
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
Copper Complexes as Anticancer Agents
Marzano, C., Pellei, M., Tisato, F., & Santini, C. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009787313837 · Cited by 802
Copper metabolism in cell death and autophagy
Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 701
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Self-citationQuinoline as a Privileged Scaffold in Cancer Drug Discovery
R. Solomon, V., & Lee, H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795328382 · Cited by 581
Metadata
- Authors
- Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R., & Dou, Q. P.
- Venue
- Breast Cancer Research
- Published
- 2005-09-20
- Volume
- 7
- Issue
- 6
- Pages
- R897-908
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W1545814905
- Cited by
- 326
- References
- 61
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.